I am presenting a poster (PP33) on “cost-effectiveness analysis of regorafenib in the treatment of advanced hepatocellular carcinoma from a Canadian perspective”
Send me a message, and I will be happy to connect at #HTAi2023Adelaide !
Talking about the redefinition of the #RedETS potfolio. We need #rapideresponse
#HTAI2023adelaide
#RedETS Ministerio de Sanidad Axencia Galega de Coñecemento en Saúde
Attended #HTAi2023Adelaide meeting, Australia!
It was a great experience sharing HTA works with all potential interest groups globally as well as leading thinkers in HTA. Thanks #AfricaCDC HEP and #just_nonvignon for facilitating this opportunity🙏
Interesting point at the final plenary at #HTAi2023Adelaide about the need for HTA to take a system-wide approach rather than assess each treatment separately #watchthisspace
#HTA i2023Adelaide going to be an informative session on new genetic and genomic tests in healthcare decisions #HTA HTAi Charles Perkins Centre University of Sydney Westmead Applied Research Centre #WARC_USYD
Excited to be attending #HTAi2023Adelaide this week starting with a workshop on hospital-based HTA. Lots of interesting insights shared by key experts in this area particularly around importance of stakeholder buy-in, engaging the right clinicians to collaborate with.
How much time does it take to be a patient? #HTA i2023Adelaide #HTA Sydney Health Westmead Applied Research Centre #WARC_USYD CKR
#HTA i2023Adelaide Assoc Prof Sarah Norris talks about the Value of Knowing in new genetic and genomic testing #HTA HTAi Sydney Health EMCR Charles Perkins Centre CPC EMCR Westmead Applied Research Centre #WARC_USYD
Great point. Difference between Patient Preference evidence and Patient Input Dr. Deborah A Marshall Research Team talking about Patient Preferences in HTA at #HTAi2023Adelaide
Is legislation holding us back with regards to advancing genomics? Tiff Boughtwood Australian Genomics explains some of the legislation that needs to change to keep up with the expansion of genomics within healthcare. #HTAi2023Adelaide
First presentation by MaHTAS delegate, Dr. Nur Farhana in 'Engaging stakeholders to strengthen health system in low and middle income countries (LMICs) moving towards universal health coverage (UHC)' session.
#HTAi2023Adelaide
“If we really care about a cost effective health system we would invest in genomics” - “You can’t put a price in health and knowledge or the value of knowing. We need genomics to give people hope”. #KrystalBartler
#HTAi2023Adelaide
MaHTAS in ADELAIDE, AUSTRALIA
25 June 2023
Dr. Erni Zurina Romli was invited to share the story of how COVID-19 pandemic had made significant impact in defining the crucial role of MaHTAS as HTA agency in Malaysia.
#HTAi2023Adelaide
#kementeriankesihatanmalaysia
𝐖𝐡𝐚𝐭 𝐦𝐚𝐧𝐚𝐠𝐞𝐫𝐢𝐚𝐥 𝐬𝐤𝐢𝐥𝐥𝐬 𝐟𝐨𝐫 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐚𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐢𝐨𝐧𝐬 𝐚𝐜𝐭𝐢𝐯𝐞 𝐢𝐧 𝐇𝐓𝐀?
Discussions and practical examples. This was the topic of an interesting panel session at #HTAi2023Adelaide .
Quality of life - the base line is different for people with #raredisease which can make it difficult to gather evidence. Interpretation of evidence can be difficult. How do you put a value on someone’s life? #HTAi2023Adelaide
Come along to my talk at #HTAi2023Adelaide on Modelling the impact of multi-indication treatments in multimorbid populations at the Gilbert Suite starting in 5 mins. If nothing else the view is gorgeous! 🤩
INAHTA at #HTAi2023Adelaide presenting 'Can Regulators and Health Technology Agencies Sing from the Same Hymn Sheet? Exploring the Benefits and Challenges'. Tuesday, 27 June 2023 at 11:10-12:25 ACST
